EUVIMEDEUVIMED entdecken
Crossref

Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches

Leena Das, Manas Das, Luit M Barkalita, Probodh Borah, Ananya Chetia, Momita Rani Baro, Ratul Chakraborty, Aashis Dutta

Inflammopharmacology · 2026-11 · 34 (11) · 7183-7203

DOI: 10.1007/s10787-026-02407-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 25.09.2026. Verfasst von Leena Das und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Animal Physiology and Biochemistry Laboratory, Gauhati University, Guwahati, Assam, 781014, India. Hauptthemen laut MEDLINE: Plant Extracts, Nitric Oxide Synthase Type II, Anti-Inflammatory Agents, Cyclooxygenase 2. Die Arbeit nennt 101 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myrica esculenta Buch. -Ham. ex D. Don, traditionally referred to as "Noga Tenga" in Assam and "Soh-Phi" by the Khasi tribe, holds a longstanding place in Indian medicine for antimicrobial, antidiabetic, and respiratory ailments. This study evaluates the anti-inflammatory potential of the methanolic extract of M. esculenta fruit (MEMEF) in LPS-challenged RAW 264.7 macrophages and a complementary in vivo system. Swiss albino male mice (n = 6) were pre-treated orally with MEMEF for seven days followed by a single intraperitoneal dose of LPS (3 mg/kg bw). Serum AST, ALT, ALP, NO, PGE2, and cytokines were measured, and inos and cox-2 mRNA expression was analyzed by qPCR. In vitro, RAW 264.7 cells were pre-treated with MEMEF (16.7 and 33.5 µg/ml) and stimulated with LPS (1 µg/ml) for 24 h. LC-MS analysis identified major phytoconstituents, and molecular docking examined interactions of epigallocatechin-3-gallate, resveratrol, and myricitrin with COX-2 and iNOS. MEMEF pre-treatment significantly reduced LPS-induced elevations of serum biochemical markers and inflammatory mediators, with qPCR confirming downregulation of inos and cox-2 in treated groups. In vitro, MEMEF markedly decreased NO and PGE2 production and suppressed inos and cox-2 expression in activated RAW 264.7 cells. Docking results showed strong binding of epigallocatechin-3-gallate to both target proteins, suggesting a possible contribution of these interactions to the observed anti-inflammatory effects. Overall, MEMEF exhibited anti-inflammatory activity in cellular and animal models, supporting its promise as a therapeutic candidate for inflammation-related disorders and highlighting its value as a source of nutraceutical supplement derived from a traditionally consumed functional fruit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsNitric Oxide Synthase Type IIAnti-Inflammatory AgentsCyclooxygenase 2InflammationMyricaAnimalsMiceMaleLipopolysaccharidesRAW 264.7 CellsFruitDietary SupplementsMolecular Docking SimulationMacrophages

Stichwörter der Autor:innen

Myrica esculentaCyclooxygenase−2CytokinesInducible nitric oxide synthaseInflammationLPS-Stimulated RAW264.7 cells

Substanzen

Plant ExtractsLipopolysaccharidesNitric Oxide Synthase Type IIAnti-Inflammatory AgentsCyclooxygenase 2Nos2 protein, mouse

Autor:innen und Institutionen

  • Department of Zoology, Animal Physiology and Biochemistry Laboratory, Gauhati University, Guwahati, Assam, 781014, India.
  • Department of Zoology, Animal Physiology and Biochemistry Laboratory, Gauhati University, Guwahati, Assam, 781014, India. manasdasne@gmail.com.
  • Department of Animal Biotechnology, College of Veterinary Science, Assam Agricultural University, Khanapara, Guwahati, Assam, 781022, India.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Das, L., Das, M., Barkalita, L. M., Borah, P., Chetia, A., Baro, M. R., Chakraborty, R., & Dutta, A. (2026). Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches. Inflammopharmacology, 34(11), 7183-7203. https://doi.org/10.1007/s10787-026-02407-y

Vancouver

Das L, Das M, Barkalita LM, Borah P, Chetia A, Baro MR, et al. Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches. Inflammopharmacology. 2026;34(11):7183-7203. doi:10.1007/s10787-026-02407-y

BibTeX
@article{Das2026,
  author = {Das, Leena and Das, Manas and Barkalita, Luit M and Borah, Probodh and Chetia, Ananya and Baro, Momita Rani and Chakraborty, Ratul and Dutta, Aashis},
  title = {Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches},
  journal = {Inflammopharmacology},
  year = {2026},
  volume = {34},
  number = {11},
  pages = {7183--7203},
  doi = {10.1007/s10787-026-02407-y}
}
Kostenlos starten →